Arrieta, Víctor A.
Gould, Andrew
Kim, Kwang-Soo
Habashy, Karl J.
Dmello, Crismita http://orcid.org/0000-0002-1688-9663
Vázquez-Cervantes, Gustavo I.
Palacín-Aliana, Irina
McManus, Graysen http://orcid.org/0009-0001-0298-0191
Amidei, Christina
Gomez, Cristal
Dhiantravan, Silpol
Chen, Li
Zhang, Daniel Y.
Saganty, Ruth
Cholak, Meghan E.
Pandey, Surya
McCord, Matthew
McCortney, Kathleen http://orcid.org/0000-0001-7085-830X
Castro, Brandyn
Ward, Rachel
Muzzio, Miguel
Bouchoux, Guillaume
Desseaux, Carole
Canney, Michael
Carpentier, Alexandre
Zhang, Bin http://orcid.org/0000-0002-6631-7647
Miska, Jason M. http://orcid.org/0000-0001-9608-2810
Lesniak, Maciej S. http://orcid.org/0000-0002-0096-5107
Horbinski, Craig M. http://orcid.org/0000-0001-8340-9992
Lukas, Rimas V.
Stupp, Roger http://orcid.org/0000-0002-5483-3118
Lee-Chang, Catalina http://orcid.org/0000-0002-7675-2124
Sonabend, Adam M. http://orcid.org/0000-0002-8347-1945
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R01NS110703-01A1, 1U19CA264338-01, P50CA221747)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA245969-01A1)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 8 March 2023
Accepted: 29 April 2024
First Online: 6 June 2024
Competing interests
: A.M. Sonabend and R. Stupp have received in-kind and or funding support for research from Agenus, BMS, and Carthera. A.M. Sonabend, V.A. Arrieta, KS. Kim, C. Amidei, and R. Stupp are co-authors of an IP filed by Northwestern University related to the content of this manuscript (“CANCER IMMUNOTHERAPIES” No. PCT/US2023/034299). A.M. Sonabend has served as consultant for Carthera and EnClear Therapies. R. Stupp has acted or is acting as a scientific advisor or has served on advisory boards for the following companies: Alpheus Medical, AstraZeneca, Boston Scientific, Carthera, Celularity, GT Medical, Insightec, Lockwood (BlackDiamond), Northwest Biotherapeutics, Novocure, Inc., Syneos Health (Boston Biomedical), TriAct Therapeutics, Varian Medical Systems. C. Desseaux, G. Bouchoux, and M. Canney are employees and hold an ownership interest in Carthera. M. Canney, G. Bouchoux, and A. Carpentier have patents related to the ultrasound technology described herein. R. Stupp is an advisory member and consultant for Carthera. A. Carpentier is a consultant for Carthera. All other authors declare no competing interests.